Idioma: Inglés
Publicado por Kluwer Academic Publishers / Plenum, NY, 2000
ISBN 10: 0306462222 ISBN 13: 9780306462221
Librería: J. HOOD, BOOKSELLERS, ABAA/ILAB, Baldwin City, KS, Estados Unidos de America
EUR 43,73
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. 368pp. Near new, clean, tight & bright condition / published without dust jacket.
Idioma: Inglés
Publicado por Kluwer/Plenum, New York, New York, U.S.A., 2000
ISBN 10: 0306462222 ISBN 13: 9780306462221
Librería: Book Booth, Berea, OH, Estados Unidos de America
EUR 51,60
Cantidad disponible: 1 disponibles
Añadir al carritoHard Cover. Condición: New. New condition. 368 pages.
EUR 65,13
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 52,39
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: ALLBOOKS1, Direk, SA, Australia
EUR 74,75
Cantidad disponible: 1 disponibles
Añadir al carritoBrand new book. Fast ship. Please provide full street address as we are not able to ship to P O box address.
EUR 87,91
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New. pp. 392.
EUR 84,78
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New. pp. 392 Illus.
EUR 89,68
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New. pp. 392.
Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America
EUR 156,12
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America
EUR 156,52
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 158,81
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 158,81
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 111,53
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - The discovery of the human T cell leukemia virus type I in the late 1970s heralded a new era in retrovirology. For the first time, it was demonstrated that a retrovirus could play a role in the development of a human disease, in this case adult T cell leukemia (ATL). Several years later, the acquired immunodeficiency syndrome (AIDS) epidemic began, and it was dem- strated that a retrovirus, originally designated the human T cell lymp- tropic virus type 3, was the causal agent of this syndrome. This virus, later named the human immunodeficiency virus type 1 (HIV-1), has since been extensively studied in terms of its pathogenesis as well as its ability to elicit immune responses. In that time, a tremendous amount of information has been obtained about the virus. Although recent drug regimens have been useful in significantly lowering viral loads and perhaps maintaining an asymptomatic state among individuals infected with HIV-1, an established 'cure' for AIDS eludes us. In addition, the effective drug therapies are very expensive, and are not available to infected people in the third world, where greater than 90% of new infections occur. Furthermore, the development of viral resistance against the drug therapies is an additional concern. Despite extensive study, no effective vaccine has been developed. One of the problems in developing an effective vaccine against HIV-1 is the ability of the virus, particularly in the immunogenic envelop glycoprotein, to undergo amino acid hypervariability.
EUR 204,31
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. 392.
EUR 178,14
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. The discovery of the human T cell leukemia virus type I in the late 1970s heralded a new era in retrovirology. For the first time, it was demonstrated that a retrovirus could play a role in the development of a human disease, in this case adult T cell leuke.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 228,69
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback. Condición: Brand New. 390 pages. 9.25x6.10x0.89 inches. In Stock.
Librería: Mispah books, Redhill, SURRE, Reino Unido
EUR 244,78
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: Like New. Like New. book.
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 247,94
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. Neuware - The discovery of the human T cell leukemia virus type I in the late 1970s heralded a new era in retrovirology. For the first time, it was demonstrated that a retrovirus could play a role in the development of a human disease, in this case adult T cell leukemia (ATL). Several years later, the acquired immunodeficiency syndrome (AIDS) epidemic began, and it was dem- strated that a retrovirus, originally designated the human T cell lymp- tropic virus type 3, was the causal agent of this syndrome. This virus, later named the human immunodeficiency virus type 1 (HIV-1), has since been extensively studied in terms of its pathogenesis as well as its ability to elicit immune responses. In that time, a tremendous amount of information has been obtained about the virus. Although recent drug regimens have been useful in significantly lowering viral loads and perhaps maintaining an asymptomatic state among individuals infected with HIV-1, an established 'cure' for AIDS eludes us. In addition, the effective drug therapies are very expensive, and are not available to infected people in the third world, where greater than 90% of new infections occur. Furthermore, the development of viral resistance against the drug therapies is an additional concern. Despite extensive study, no effective vaccine has been developed. One of the problems in developing an effective vaccine against HIV-1 is the ability of the virus, particularly in the immunogenic envelop glycoprotein, to undergo amino acid hypervariability.
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
EUR 53,74
Cantidad disponible: Más de 20 disponibles
Añadir al carritoPAP. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
EUR 59,22
Cantidad disponible: Más de 20 disponibles
Añadir al carritoPAP. Condición: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 106,99
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The discovery of the human T cell leukemia virus type I in the late 1970s heralded a new era in retrovirology. For the first time, it was demonstrated that a retrovirus could play a role in the development of a human disease, in this case adult T cell leukemia (ATL). Several years later, the acquired immunodeficiency syndrome (AIDS) epidemic began, and it was dem- strated that a retrovirus, originally designated the human T cell lymp- tropic virus type 3, was the causal agent of this syndrome. This virus, later named the human immunodeficiency virus type 1 (HIV-1), has since been extensively studied in terms of its pathogenesis as well as its ability to elicit immune responses. In that time, a tremendous amount of information has been obtained about the virus. Although recent drug regimens have been useful in significantly lowering viral loads and perhaps maintaining an asymptomatic state among individuals infected with HIV-1, an established 'cure' for AIDS eludes us. In addition, the effective drug therapies are very expensive, and are not available to infected people in the third world, where greater than 90% of new infections occur. Furthermore, the development of viral resistance against the drug therapies is an additional concern. Despite extensive study, no effective vaccine has been developed. One of the problems in developing an effective vaccine against HIV-1 is the ability of the virus, particularly in the immunogenic envelop glycoprotein, to undergo amino acid hypervariability. 392 pp. Englisch.
Librería: moluna, Greven, Alemania
EUR 100,58
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The discovery of the human T cell leukemia virus type I in the late 1970s heralded a new era in retrovirology. For the first time, it was demonstrated that a retrovirus could play a role in the development of a human disease, in this case adult T cell leuke.
Librería: preigu, Osnabrück, Alemania
EUR 141,20
Cantidad disponible: 5 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Human Retroviral Infections | Immunological and Therapeutic Control | Kenneth E. Ugen (u. a.) | Taschenbuch | xxii | Englisch | 2013 | Springer US | EAN 9781475781687 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.
Librería: Majestic Books, Hounslow, Reino Unido
EUR 213,70
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand pp. 392 49:B&W 6.14 x 9.21 in or 234 x 156 mm (Royal 8vo) Perfect Bound on White w/Gloss Lam.
Idioma: Inglés
Publicado por Springer US, Springer New York Mär 2013, 2013
ISBN 10: 1475781687 ISBN 13: 9781475781687
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 160,49
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The discovery of the human T cell leukemia virus type I in the late 1970s heralded a new era in retrovirology. For the first time, it was demonstrated that a retrovirus could play a role in the development of a human disease, in this case adult T cell leukemia (ATL). Several years later, the acquired immunodeficiency syndrome (AIDS) epidemic began, and it was dem- strated that a retrovirus, originally designated the human T cell lymp- tropic virus type 3, was the causal agent of this syndrome. This virus, later named the human immunodeficiency virus type 1 (HIV-1), has since been extensively studied in terms of its pathogenesis as well as its ability to elicit immune responses. In that time, a tremendous amount of information has been obtained about the virus. Although recent drug regimens have been useful in significantly lowering viral loads and perhaps maintaining an asymptomatic state among individuals infected with HIV-1, an established ¿cure¿ for AIDS eludes us. In addition, the effective drug therapies are very expensive, and are not available to infected people in the third world, where greater than 90% of new infections occur. Furthermore, the development of viral resistance against the drug therapies is an additional concern. Despite extensive study, no effective vaccine has been developed. One of the problems in developing an effective vaccine against HIV-1 is the ability of the virus, particularly in the immunogenic envelop glycoprotein, to undergo amino acid hypervariability.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 392 pp. Englisch.
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 218,83
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND pp. 392.